Cargando…

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways

Protein kinases (PKs) have been recognized as central nervous system (CNS)-disease-relevant targets due to their master regulatory role in different signal transduction cascades in the neuroscience space. Among them, GSK-3β, FYN, and DYRK1A play a crucial role in the neurodegeneration context, and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Demuro, Stefania, Di Martino, Rita M. C., Ortega, Jose A., Cavalli, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396491/ https://www.ncbi.nlm.nih.gov/pubmed/34445804 http://dx.doi.org/10.3390/ijms22169098

Ejemplares similares

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
por: Shen, Weijun, et al.
Publicado: (2015)

Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis
por: Woo, Youngsik, et al.
Publicado: (2019)

DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3β on eIF2Bε
por: Weiss, Celine S., et al.
Publicado: (2013)

GSK3β, a Master Kinase in the Regulation of Adult Stem Cell Behavior
por: Racaud-Sultan, Claire, et al.
Publicado: (2021)

GSK3 as a Master Regulator of Cellular Processes
por: Lichtinghagen, Ralf, et al.
Publicado: (2023)

The GSK-3β/Fyn/Nrf2 pathway in fibroblasts and wounds of type 2 diabetes: On the road to an evidence-based therapy of non-healing wounds
por: Bitar, Milad S.
Publicado: (2012)

GSK-3 in Neurodegenerative Diseases
por: Lei, Peng, et al.
Publicado: (2011)

Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation
por: Xuan, Yue, et al.
Publicado: (2022)

Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation by modulating NLRP3, DYRK1A, and GSK3α/β
por: Park, Jin-Hee, et al.
Publicado: (2023)

Increased plasma DYRK1A with aging may protect against neurodegenerative diseases
por: Delabar, Jean M., et al.
Publicado: (2023)

Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway
por: Xin, Ying, et al.
Publicado: (2018)

Fyn regeneration
por: Short, Ben
Publicado: (2012)

Mango ginger (Curcuma amada Roxb.) may alleviate the effect of high‐fat diet/streptozotocin‐induced diabetes by activation of the GSK‐3β/Fyn/Nrf2 pathway
por: Yazici, Emrah, et al.
Publicado: (2023)

The Role of Fucoxanthin as a Potent Nrf2 Activator via Akt/GSK-3β/Fyn Axis against Amyloid-β Peptide-Induced Oxidative Damage
por: Lee, Nayoung, et al.
Publicado: (2023)

GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness
por: Duda, Przemysław, et al.
Publicado: (2020)

GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier?
por: Balboni, Beatrice, et al.
Publicado: (2023)

ODP201 Fyn regulates sarcopenia via autophagy
por: Yamada, Eijiro, et al.
Publicado: (2022)

Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays
por: Balboni, Beatrice, et al.
Publicado: (2022)

Functional Roles of DYRK2 as a Tumor Regulator
por: Mochimaru, Yuta, et al.
Publicado: (2023)

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022)

Fyn specifically Regulates the activity of red cell glucose-6-phosphate-dehydrogenase
por: Alessandro, Matte’, et al.
Publicado: (2020)

Emerging Roles of DYRK Kinases in Embryogenesis and Hedgehog Pathway Control
por: Singh, Rajeev, et al.
Publicado: (2017)

Regulation of Fyn Through Translocation of Activated Lck into Lipid Rafts
por: Filipp, Dominik, et al.
Publicado: (2003)

FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family
por: Schmoker, Anna M., et al.
Publicado: (2020)

Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
por: Dirice, Ercument, et al.
Publicado: (2016)

Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective
por: Grygier, Przemyslaw, et al.
Publicado: (2023)

GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
por: Silva-García, Octavio, et al.
Publicado: (2020)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Fyn Mediates Leptin Actions in the Thymus of Rodents
por: Girasol, Alessandra, et al.
Publicado: (2009)

Hesperetin Inhibits Sphingosylphosphorylcholine-Induced Vascular Smooth Muscle Contraction by Regulating the Fyn/Rho-Kinase Pathway
por: Lu, Qian, et al.
Publicado: (2022)

Protective Effects of Ischemic Postconditioning on Livers in Rats with Limb Ischemia-Reperfusion via Glycogen Synthase Kinase 3 beta (GSK-3β)/Fyn/Nuclear Receptor-Erythroid-2-Related Factor (Nrf2) Pathway
por: Niu, Qibing, et al.
Publicado: (2020)

GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation
por: Gozdz, Agata, et al.
Publicado: (2017)

Revisiting the Proposition of Binding Pockets and Bioactive Poses for GSK-3β Allosteric Modulators Addressed to Neurodegenerative Diseases
por: Silva, Guilherme M., et al.
Publicado: (2021)

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β‐catenin signaling pathway
por: Chen, Yan, et al.
Publicado: (2021)

Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn
por: Bloch-Queyrat, Coralie, et al.
Publicado: (2005)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Tim-3 regulates the immunosuppressive function of decidual MDSCs via the Fyn-STAT3-C/EBPβ pathway during Toxoplasma gondii infection
por: Qi, Houbao, et al.
Publicado: (2023)

Overcoming barriers and thresholds – signaling of oligomeric Aβ through the prion protein to Fyn
por: Wang, Hansen, et al.
Publicado: (2013)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lnt24h1m8b0nthcpdek17semo8